A Candidate Gene Analysis of Methylphenidate Response in Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 48, Issue 12, 2009, Pages 1155-1164

  McGough, James J ^a   McCracken, James T ^a   Loo, Sandra K ^a   Manganiello, Marc ^a   Leung, Michael C ^a   Tietjens, Jeremy R ^a   Trinh, Thao ^a   Baweja, Shilpa ^a   Suddath, Robert ^a   Smalley, Susan L ^a   Hellemann, Gerhard ^a   Sugar, Catherine A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ADHD; candidate genes; methylphenidate; pharmacogenetics

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; METHYLPHENIDATE; NORADRENALIN TRANSPORTER; PLACEBO; SEROTONIN TRANSPORTER; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; AUTONOMIC DYSFUNCTION; CHILD; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RELEASE; EXAMINATION; EXON; FEMALE; GENE DELETION; GENE DOSAGE; GENE INSERTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; INDEL MUTATION; INTRON; IRRITABILITY; LEARNING; MAJOR CLINICAL STUDY; MALE; MATHEMATICS; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; RATING SCALE; SCHOOL CHILD; SIDE EFFECT; SOMATOFORM DISORDER; TREATMENT OUTCOME; TREATMENT RESPONSE; VARIABLE NUMBER OF TANDEM REPEAT;

ACHIEVEMENT; ADOLESCENT; AROUSAL; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CATECHOL O-METHYLTRANSFERASE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CROSS-OVER STUDIES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EXONS; FEMALE; GENE DOSAGE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INDEL MUTATION; INTRONS; IRRITABLE MOOD; MALE; MATHEMATICS; METHYLPHENIDATE; MINISATELLITE REPEATS; PHARMACOGENETICS; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; RECEPTORS, DOPAMINE D4; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TREATMENT OUTCOME;

EID: 71649097398     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1097/CHI.0b013e3181bc72e3     Document Type: Article

References (56)

1. McGough J.J. Attention-deficit/hyperactivity disorder pharmacogenomics. Biol Psychiatry 57 (2005) 1367-1373
2. Polanczyk G., Zeni C., Genro J.P., Roman T., Hutz M.H., and Rohde L.A. Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics. Pharmacogenomics 6 (2005) 225-234
3. Stein M.A., and McGough J.J. The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy. Child Adolesc Psychiatr Clin N Am 17 (2008) 475-490
4. Froehlich TE, McGough JJ, Stein MA. Progress and promise of ADHD pharmacogenetics. CNS Drugs. In press.
5. Greenhill L., Abikoff H., Arnold L.E., et al. Medication treatment strategies in the MTA: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 35 (1996) 1304-1313
6. Charach A., Ickowicz A., and Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse events. J Am Acad Child Adolesc Psychiatry 43 (2004) 559-567
7. Cook E.H., Stein M.A., Krasowski M.D., et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56 (1995) 993-998
8. Faraone S.V., Perlis R.H., Doyle A.E., et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57 (2005) 1313-1323
9. Ogdie M.N., Macphie I.L., Minassian S.L., et al. A genome-wide scan for attention-deficit/hyperactivity disorder: suggestive linkage on 17p11. Am J Hum Genet 72 (2003) 1268-1279
10. Mick E., and Faraone S. Genetics of attention deficit hyperactivity disorder. Child Adolesc Psychiatric Clin N Am 17 (2008) 261-284
11. Kirley A., Lowe N., Hawi Z., et al. Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. Am J Med Genet B Neuropsychiatr Genet 121B (2003) 50-54
12. Langley K., Turic D., Peirce T.R., et al. No support for association between the dopamine transporter (DAT1) gene and ADHD. Am J Med Genet B Neuropsychiatr Genet 139B (2005) 7-10
13. Tahir E., Yazgan Y., Cirakoglu B., Ozbay F., Waldman I., and Asherson P.J. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol Psychiatry 5 (2000) 396-404
14. Van der meulen E.M., Bakker S.C., Pauls D.L., et al. High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD. J Child Psychol Psychiatry 46 (2005) 1074-1080
15. Cheon K.A., Ryu Y.H., Kim J.W., and Cho D.Y. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. Eur Neuropsychopharmacol 15 (2005) 95-101
16. Cheon K.A., Kim B.N., and Cho S.C. Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children. Neuropsycho-pharmacology 32 (2007) 1377-1383
17. da Silva T.L., Pianca T.G., Roman T., et al. Adrenergic {A figure is presented}2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominately inattentive type. J Neural Transm 115 (2008) 341-345
18. Hamarman S., Fossella J., Ulger C., Brimacombe M., and Dermody J. Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention-deficit/hyperactivity disorder: a pharmacogenetic study. J Child Adolesc Psychopharmacol 14 (2004) 564-574
19. Joober R., Grizenko N., Sengupta S., et al. Dopamine transporter 3′-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate. Neuropsychopharmacology 32 (2007) 1370-1376
20. Kooij J.S., Boonstra A., Vermeulen S.H., et al. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1). Am J Med Genet B Neuropsychiatr Genet 147B (2008) 201-208
21. McGough J.J., McCracken J.T., Swanson J., et al. Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 45 (2006) 1314-1322
22. Mick E., Biederman J., Spencer T., Faraone S.V., and Sklar P. Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD. Am J Med Genet B Neuropsychiatr Genet 141B (2006) 890-894
23. Stein M.A., Waldman I.D., Sarampote C.S., et al. Dopamine transporter genotype with methylphenidate dose response in children with ADHD. Neuropsychopharmacology 30 (2005) 1374-1382
24. Polanczyk G., Zeni C., Genro J.P., et al. Association of the adrenergic α2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescent with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 64 (2007) 218-224
25. Purper-Ouakil D., Wohl M., Orejarena S., et al. Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: association with the dopamine transporter gene (SLC6A3). Am J Med Genet B Neuropsychiatr Genet 147B (2008) 1425-1430
26. Seeger G., Schloss P., and Schmidt M.H. Marker gene polymorphisms in hyperkinetic disorder - predictors of clinical response to treatment with methylphenidate?. Neurosci Lett 313 (2001) 45-48
27. Winsberg B.G., and Comings D.E. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J Am Acad Child Adolesc Psychiatry 38 (1999) 1474-1477
28. Yang L., Wang Y.F., Li J., and Faraone S.V. Association of norepinephrine transporter gene with methylphenidate response. J Am Acad Child Adolesc Psychiatry 43 (2004) 1154-1158
29. Roman T., Szobot C., Martins S., Biederman J., Rohde L.A., and Hutz M.H. Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder. Pharmacogenetics 12 (2000) 497-499
30. Zeni S.P., Guimarães A.P., Polanczyk G.V., et al. No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 144B (2007) 391-393
31. Tharoor H., Lobos E.A., Todd R.D., and Reiersen A.M. Association of dopamine, serotonin, and nicotine gene polymorphisms with methylphenidate response in ADHD. Am J Med Genet B Neuropsychiatr Genet 147B (2008) 527-530
32. Kaufman A.S., and Kaufman N.L. Kaufman Brief Intelligence Test. 1st ed (1990), American Guidance Service, Circle Pines, MN
33. Kaufman J., Birmaher B., Brent D., et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (KSADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36 (1997) 980-988
34. Abikoff H., McGough J., Vitiello B., et al. Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity disorder and anxiety disorders. J Am Acad Child Adolesc Psychiatry 44 (2005) 418-427
35. Greenhill L.L., Kollins S., Abikoff H., et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 45 (2006) 1284-1293
36. Swanson J.M., Agler D., and Fineberg E. Laboratory school protocol for pharmacokinetic and pharmacodynamic studies. In: Greenhill L.L., and Osman B.B. (Eds). Ritalin: Theory and Practice (2000), Mary Ann Leibert, New York
37. DuPaul G.J., Power T.J., Anastopoulos A.D., and Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation (1998), Guilford Press, New York
38. Faries D.E., Yalcon I., Harder D., and Heilengenstein J.H. Validation of the ADHD Rating Scale as a clinician administered and scored instrument. J Atten Disord 5 (2001) 107-115
39. Swanson J.M., Schuck S., Mann M., et al. Categorical and dimensional definitions and evaluations of ADHD: the SNAP and SWAN ratings scales. http://www.adhd.net/ Accessed June 12, 2009.
40. MTA Cooperative Group. 14-Month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56 (1999) 1073-1086
41. Pelham W. Pharmacotherapy for children with attention deficit hyperactivity disorder. School Psychol Rev 22 (1993) 199-227
42. Wigal T., Greenhill L., Chuang S., et al. Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry 45 (2006) 1294-1303
43. Lott D.C., Kim S.J., Cook E.H., and deWit H. Serotonin transporter genotype and acute subjective response to amphetamine. Am J Addict 15 (2006) 327-335
44. McCracken J.T., Smalley S.L., McGough J.J., et al. Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Mol Psychiatry 5 (2000) 531-536
45. Shaikh S., Collier D., Kerwin R.W., et al. Dopamine D4 receptor subtypes and response to clozapine. Lancet 341 (1993) 689-690
46. Stöber G., Nöthen M.M., Pörzgen P., et al. Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet 67 (1996) 523-532
47. Barr C.L., Feng Y., Wigg K., et al. Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit/hyperactivity disorder. Mol Psychiatry 5 (2000) 405-409
48. SAS [computer program]. Version 9.1 (2006), SAS Institute, Cary, NC
49. Cohen J., Cohen P., West S.G., and Aiken L.S. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences. 3rd ed (2003), Erlbaum, Mahwah, NJ
50. Rapport M.D., and Denney C. Titrating methylphenidate in children with attention-deficit/hyperactivity disorder; is body mass predictive of clinical response?. J Am Acad Child Adolesc Psychiatry 36 (1997) 523-530
51. Sprague R.L., and Sleator E.K. Methylphenidate in hyperkinetic children; differences in dose effects on learning and social behavior. Science 198 (1997) 1274-1276
52. Pelham W.E., and Millich R. Individual differences in response to Ritalin in class work and social behavior. In: Greenhill L.L., and Osman B.B. (Eds). Ritalin: Theory and Practice (1991), Mary Ann Leibert, New York
53. Gan J., and Cantwell D.P. Dosage effects of methylphenidate on paired associate learning: positive/negative placebo responders. J Am Acad Child Adolesc Psychiatry 21 (1982) 237-242
54. Baune B.T., Hohoff C., Berger K., et al. Association of the COMT val158met variant with antidepressant response in major depression. Neuropsychopharmacology 33 (2008) 924-932
55. Weickert T.W., Goldberg T.E., Mishara A., et al. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications. Biol Psychiatry 56 (2004) 677-682
56. Hu X.Z., Lipsky R.H., Zhu G., et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78 (2006) 815-826